Phase 1 Study of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Lue, Jennifer Kimberly, Stevens, Don A., Williams, Michael E., Westin, Jason, Ewesuedo, Reggie, McDonald, Alice, Agarwal, Sagar, Henrick, Patrick, Perea, Rachelle, Gollob, Jared
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
TABLET: Relative bioavailability and bioequivalence study of niraparib tablets and capsules in patients with advanced solid tumors
Falchook, Gerald Steven, Patnaik, Amita, Sharma, Manish, Harvey, R. Donald, Hamilton, Erika P., Hafez, Navid, Wise-Draper, Trisha M., Barve, Minal A., Patel, Manish R., Dowlati, Afshin, Richardson, Debra L., Faltermeier, Christina, Ewesuedo, Reggie, Kneissl, Michelle, Potocka, Elizabeth
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
A Phase 1 Study of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors
Smith, Stephen D, Starodub, Alexander, Stevens, Don A., Shastri, Aditi, Porcu, Pierluigi, Feldman, Tatyana, Ewesuedo, Reggie, DeSavi, Chris, Dey, Joyoti, Agarwal, Sagar, Donohue, Sean, Perea, Rachelle, Klaus, Christine, Gollob, Jared
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
Mayo, Michele, Chutake, Yogesh, Karnik, Rahul, McDonald, Alice, Cho, Patricia S., Filiatrault, Jessica, Chen, Dapeng, Dixit, Vaishali, Proctor, William, Breitkopf, Susanne, Qi, Frank, Hu, Kan-Nian, Sharma, Kirti, Ewesuedo, Reggie, Weiss, Matt, Growney, Joseph D., Williams, Juliet, Schalm, Stefanie S
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article